Skip to main content

Status Epilepticus

  • Chapter
  • First Online:
Neurological Emergencies

Abstract

Status epilepticus (SE) is a neurologic emergency given its high mortality and morbidity potential and takes place when physiologic mechanisms of seizure termination are impaired or overwhelmed. Over the course of several decades, multiple SE definitions have been proposed based on seizure duration and clinical semiology of seizures, therapeutic response (or lack thereof), and etiology. These definitions target a more precise characterization of each clinical syndrome associated with SE, which has distinct prognostic and therapeutic implications. Given the significant morbidity and mortality associated with SE, early diagnosis and treatment is of utmost importance. The clinical exam and electroencephalography remain the mainstays of diagnosis and assist in guiding therapeutic approaches, which include timely administration of first-line therapy (benzodiazepines) and a subsequent tiered approach that may include non-sedating medications, deep anesthesia, immunotherapy, ketogenic diet, and empiric surgery in selected cases. National and international guidelines are available to assist with a standardized approach to SE; however, in clinical practice, it is imperative to individualize therapy according to the etiology of seizures, patient’s comorbidities, and the nature of seizures (convulsive vs nonconvulsive, focal vs generalized). This chapter provides a focused yet comprehensive review of SE, including proposed definitions, pathophysiology, etiology, epidemiology, diagnosis, treatment, complications, and prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Betjemann JP, Josephson SA, Lowenstein DH, Burke JF. Trends in status epilepticus-related hospitalizations and mortality: redefined in US practice over time. JAMA Neurol. 2015;72(6):650–5.

    Article  PubMed  Google Scholar 

  2. Sanchez S, Rincon F. Status epilepticus: epidemiology and public health needs. J Clin Med. 2016;5(8).

    Article  PubMed Central  Google Scholar 

  3. Alvarez V, Lee JW, Westover MB, Drislane FW, Novy J, Faouzi M, et al. Therapeutic coma for status epilepticus: differing practices in a prospective multicenter study. Neurology. 2016;87(16):1650–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus—report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56(10):1515–23.

    Article  PubMed  Google Scholar 

  5. Chakraborty T, Hocker S. The clinical spectrum of new-onset status epilepticus. Crit Care Med. 2019;47:970.

    Article  PubMed  Google Scholar 

  6. Hirsch LJ, LaRoche SM, Gaspard N, Gerard E, Svoronos A, Herman ST, et al. American Clinical Neurophysiology Society’s standardized critical care EEG terminology: 2012 version. J Clin Neurophysiol. 2013;30(1):1–27.

    Article  CAS  PubMed  Google Scholar 

  7. Nagayama M, Yang S, Geocadin RG, Kaplan PW, Hoshiyama E, Shiromaru-Sugimoto A, et al. Novel clinical features of nonconvulsive status epilepticus. F1000Res. 2017;6:1690.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E, et al. Salzburg consensus criteria for non-convulsive status epilepticus—approach to clinical application. Epilepsy Behav. 2015;49:158–63.

    Article  CAS  Google Scholar 

  9. Hirsch LJ, Gaspard N, van Baalen A, Nabbout R, Demeret S, Loddenkemper T, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739–44.

    Article  PubMed  Google Scholar 

  10. Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015;14(6):615–24.

    Article  PubMed  Google Scholar 

  11. Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care. 2014;20(3):476–83.

    Article  PubMed  Google Scholar 

  12. Delaj L, Novy J, Ryvlin P, Marchi NA, Rossetti AO. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study. Acta Neurol Scand. 2017;135(1):92–9.

    Article  PubMed  Google Scholar 

  13. Kantanen AM, Kalviainen R, Parviainen I, Ala-Peijari M, Backlund T, Koskenkari J, et al. Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study. Crit Care. 2017;21(1):71.

    Google Scholar 

  14. Ferlisi M, Hocker S, Grade M, Trinka E, Shorvon S. Preliminary results of the global audit of treatment of refractory status epilepticus. Epilepsy Behav. 2015;49:318–24.

    Google Scholar 

  15. Spatola M, Novy J, Du Pasquier R, Dalmau J, Rossetti AO. Status epilepticus of inflammatory etiology: a cohort study. Neurology. 2015;85(5):464–70.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hocker S, Nagarajan E, Rabinstein AA, Hanson D, Britton JW. Progressive brain atrophy in super-refractory status epilepticus. JAMA Neurol. 2016;73(10):1201–7.

    Article  PubMed  Google Scholar 

  17. Benbadis SR, Chen S, Melo M. What’s shaking in the ICU? The differential diagnosis of seizures in the intensive care setting. Epilepsia. 2010;51(11):2338–40.

    Article  PubMed  Google Scholar 

  18. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792–8.

    Article  CAS  PubMed  Google Scholar 

  19. Bialer M, White HS. Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov. 2010;9(1):68–82.

    Article  CAS  PubMed  Google Scholar 

  20. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.

    Article  PubMed  Google Scholar 

  21. Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48–61.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Strzelczyk A, Zollner JP, Willems LM, Jost J, Paule E, Schubert-Bast S, et al. Lacosamide in status epilepticus: systematic review of current evidence. Epilepsia. 2017;58(6):933–50.

    Article  CAS  PubMed  Google Scholar 

  23. Höfler J, Trinka E. Intravenous ketamine in status epilepticus. Epilepsia. 2018;59(Suppl 2):198–206. Epub 2018 Aug 26

    Article  PubMed  Google Scholar 

  24. Cervenka MC, Hocker S, Koenig M, Bar B, Henry-Barron B, Kossoff EH, et al. Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology. 2017;88(10):938–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Legriel S, Lemiale V, Schenck M, Chelly J, Laurent V, Daviaud F, et al. Hypothermia for neuroprotection in convulsive status epilepticus. N Engl J Med. 2016;375(25):2457–67.

    Article  PubMed  Google Scholar 

  26. Basha MM, Suchdev K, Dhakar M, Kupsky WJ, Mittal S, Shah AK. Acute resective surgery for the treatment of refractory status epilepticus. Neurocrit Care. 2017;27(3):370–80.

    Article  PubMed  Google Scholar 

  27. Marienke AAM, Bruijn d, van Sonderen A, van Coevorden-Hameete MH, et al. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis. Neurology. 2019 May 7;92(19):e2185–96.

    Google Scholar 

  28. Hocker S. Systemic complications of status epilepticus—an update. Epilepsy Behav. 2015;49:83–7.

    Article  Google Scholar 

  29. Neligan A, Shorvon SD. Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol. 2010;67(8):931–40.

    Google Scholar 

  30. Giovannini G, Monti G, Tondelli M, Marudi A, Valzania F, Leitinger M, et al. Mortality, morbidity and refractoriness prediction in status epilepticus: comparison of STESS and EMSE scores. Seizure. 2017;46:31–7.

    Article  PubMed  Google Scholar 

  31. Leitinger M, Holler Y, Kalss G, Rohracher A, Novak HF, Hofler J, et al. Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care. 2015;22(2):273–82.

    Article  Google Scholar 

  32. Neligan A, Noyce AJ, Gosavi TD, Shorvon SD, Köhler S, Walker MC. Change in mortality of generalized convulsive status epilepticus in high-income countries over time. JAMA Neurol. 2019.

    Google Scholar 

  33. Rajiv KR, Radhakrishnan A. Status epilepticus in pregnancy: etiology, management, and clinical outcomes. Epilepsy Behav. 2017;76:114–9.

    Article  Google Scholar 

  34. Dragancea I, Backman S, Westhall E, Rundgren M, Friberg H, Cronberg T. Outcome following postanoxic status epilepticus in patients with targeted temperature management after cardiac arrest. Epilepsy Behav. 2015;49:173–7.

    Article  Google Scholar 

  35. Canas N, Delgado H, Silva V, Pinto AR, Sousa S, Simoes R, et al. The electroclinical spectrum, etiologies, treatment and outcome of nonconvulsive status epilepticus in the elderly. Epilepsy Behav. 2018;79:53–7.

    Article  Google Scholar 

Download references

Disclosures

Dr. Carolina B. Maciel reports no disclosures.

Dr. Michael D. Morris reports no disclosures.

Dr. Kent A. Owusu received funding from the Swebilius foundation for a retrospective study comparing different benzodiazepine regimens for seizure termination and seizure cluster prevention in patients admitted to the adult Epilepsy Monitoring Unit.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carolina B. Maciel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Morris, M.D., Owusu, K.A., Maciel, C.B. (2020). Status Epilepticus. In: Rabinstein, A. (eds) Neurological Emergencies. Springer, Cham. https://doi.org/10.1007/978-3-030-28072-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28072-7_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28071-0

  • Online ISBN: 978-3-030-28072-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics